Efficacy of a plant-produced clade 2.3.4.4 H5 influenza virus-like particle vaccine in layer hens

Celia Abolnik , Martha M. O'Kennedy , Mark-Anthony Murphy , Daniel B.R. Wandrag
{"title":"Efficacy of a plant-produced clade 2.3.4.4 H5 influenza virus-like particle vaccine in layer hens","authors":"Celia Abolnik ,&nbsp;Martha M. O'Kennedy ,&nbsp;Mark-Anthony Murphy ,&nbsp;Daniel B.R. Wandrag","doi":"10.1016/j.vetvac.2022.100001","DOIUrl":null,"url":null,"abstract":"<div><p>Outbreaks caused by Goose/Guangdong H5 highly pathogenic avian influenza (HPAI)-lineage viruses continue to occur in unprecedented numbers throughout Eurasia, the Middle East and Africa, causing billions of dollars in economic losses and the deaths or destruction of hundreds of millions of poultry, and pose a zoonotic threat. Here, a recombinant virus-like particle (VLP) displaying the hemagglutinin protein of a clade 2.3.4.4b H5N8 HPAI strain was produced in tobacco plants (<em>Nicotiana benthamiana</em>) and its immunogenicity with four commercial adjuvants was compared in layer hens. After two immunizations with 250 hemagglutinating unit doses, hens that received intramuscular injections of H5 VLPs formulated with Emulsigen D, Emulsigen P or Montanide ISA 71VG seroconverted with hemagglutination inhibition geometric mean titres (GMTs) of 7.3 log<sub>2</sub> (± 1.17), 8 log<sub>2</sub> (± 1.08) and 7.9 log<sub>2</sub> (±1.07), respectively, but the GMT of hens inoculated by eye drop with VLPs plus Carbigen only reached 2.05 log<sub>2</sub> (± 1.64). The H5 VLP plus Emulsigen-P vaccinated hens and a sham-vaccinated group were then challenged with a high dose of the homologous H5N8 HPAI virus. Vaccinated hens were completely protected and showed no clinical signs, whereas the sham-vaccinated birds all died within 3–4 days. The average oropharyngeal shedding in vaccinated hens was reduced by 3,487-fold and 472-fold on days 2 and 3 post challenge, respectively, whereas average cloacal shedding was reduced by 2,360,098-fold and 15,608-fold on days 2 and 3, respectively, compared to the sham-vaccinated controls. No virus was detected in the vaccinated hens after day 8 post challenge, and the plant-produced H5 VLP vaccine completely prevented H5N8 HPAI virus transmission to eggs. This highly efficacious, safe and non-toxic plant-produced H5 VLP vaccine with DIVA (differentiation of infected from vaccinated animals) capability could be rapidly produced with a yield of at least 85,000 doses per Kg of plant leaf material.</p></div>","PeriodicalId":101273,"journal":{"name":"Veterinary Vaccine","volume":"1 1","pages":"Article 100001"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772535922000014/pdfft?md5=71f1b163e0b4d3cacce22d6129147d25&pid=1-s2.0-S2772535922000014-main.pdf","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary Vaccine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772535922000014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Outbreaks caused by Goose/Guangdong H5 highly pathogenic avian influenza (HPAI)-lineage viruses continue to occur in unprecedented numbers throughout Eurasia, the Middle East and Africa, causing billions of dollars in economic losses and the deaths or destruction of hundreds of millions of poultry, and pose a zoonotic threat. Here, a recombinant virus-like particle (VLP) displaying the hemagglutinin protein of a clade 2.3.4.4b H5N8 HPAI strain was produced in tobacco plants (Nicotiana benthamiana) and its immunogenicity with four commercial adjuvants was compared in layer hens. After two immunizations with 250 hemagglutinating unit doses, hens that received intramuscular injections of H5 VLPs formulated with Emulsigen D, Emulsigen P or Montanide ISA 71VG seroconverted with hemagglutination inhibition geometric mean titres (GMTs) of 7.3 log2 (± 1.17), 8 log2 (± 1.08) and 7.9 log2 (±1.07), respectively, but the GMT of hens inoculated by eye drop with VLPs plus Carbigen only reached 2.05 log2 (± 1.64). The H5 VLP plus Emulsigen-P vaccinated hens and a sham-vaccinated group were then challenged with a high dose of the homologous H5N8 HPAI virus. Vaccinated hens were completely protected and showed no clinical signs, whereas the sham-vaccinated birds all died within 3–4 days. The average oropharyngeal shedding in vaccinated hens was reduced by 3,487-fold and 472-fold on days 2 and 3 post challenge, respectively, whereas average cloacal shedding was reduced by 2,360,098-fold and 15,608-fold on days 2 and 3, respectively, compared to the sham-vaccinated controls. No virus was detected in the vaccinated hens after day 8 post challenge, and the plant-produced H5 VLP vaccine completely prevented H5N8 HPAI virus transmission to eggs. This highly efficacious, safe and non-toxic plant-produced H5 VLP vaccine with DIVA (differentiation of infected from vaccinated animals) capability could be rapidly produced with a yield of at least 85,000 doses per Kg of plant leaf material.

一种植物产进化枝2.3.4.4 H5流感病毒样颗粒疫苗对蛋鸡的效果观察
鹅/广东H5高致病性禽流感(HPAI)谱系病毒在欧亚大陆、中东和非洲继续以前所未有的数量暴发,造成数十亿美元的经济损失和数亿家禽的死亡或破坏,并构成人畜共患威胁。本研究在烟草(Nicotiana benthamiana)中制备了一种含有HPAI分支2.3.4.4b H5N8血凝素蛋白的重组病毒样颗粒(VLP),并比较了其与4种商用佐剂在蛋鸡中的免疫原性。经250单位剂量的两次免疫后,肌肉注射由乳素D、乳素P和蒙塔尼德ISA 71VG配制的H5 VLPs,其血凝抑制几何平均滴度(GMTs)分别为7.3 log2(±1.17)、8 log2(±1.08)和7.9 log2(±1.07),而滴眼液中加入Carbigen的VLPs的GMTs仅为2.05 log2(±1.64)。然后用高剂量的同源H5N8 HPAI病毒攻击H5 VLP +乳化剂- p疫苗组和假疫苗组。接种疫苗的母鸡完全受到保护,没有表现出任何临床症状,而假接种疫苗的鸡在3-4天内全部死亡。与假接种疫苗的对照组相比,接种疫苗的母鸡在攻击后第2天和第3天的口咽平均脱落量分别减少了3,487倍和472倍,而在第2天和第3天的阴道口平均脱落量分别减少了2,36,098倍和15,608倍。攻毒后第8天,接种鸡体内未检出病毒,植物生产的H5 VLP疫苗完全阻止了H5N8 HPAI病毒向鸡蛋的传播。这种高效、安全、无毒的植物生产的H5 VLP疫苗具有DIVA(被感染动物与接种动物的区分)能力,可以快速生产,每公斤植物叶片材料的产量至少为85,000剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信